There are 3 different areas of healthcare that all face different challenges in implementing population health and adopting new reimbursement models, explained Peter Aran, MD, medical director of Population Health Management at Blue Cross Blue Shield of Oklahoma.
There are 3 different areas of healthcare that all face different challenges in implementing population health and adopting new reimbursement models, explained Peter Aran, MD, medical director of Population Health Management at Blue Cross Blue Shield of Oklahoma.
Transcript
What are the differences in adopting new reimbursement models within a healthcare system versus a community practice?
One of the biggest challenges that is going to keep getting bigger, is that as health systems buy private practices, health systems are coming at value-based care from a different perspective than a private practice may come at value-based care. In some markets fee-for-service is still the king, and some of us believe that fee-for-service will always play some role in healthcare delivery, but it’s going to have a diminishing role over time. So when CMS is talking about 50%, 60%, 70%, 80% value-based care reimbursements for quality care reimbursed in this way in the next 2 or 3 years, we think that maybe it won’t be quite that much, but that will happen over time.
And so health systems in some markets are still fee-for-service based, and we have to work with that. Private groups are easier to work with in the sense that aspects of their business plan, such as admissions or readmissions or on-site radiologic studies, or on-site laboratory studies, which oftentimes are more expensive than off-site studies, that isn’t in their business models. So it’s easier to work with that part of the whole total cost picture. So that’s one aspect.
And then the third group that I’m going to mention, because it’s a fascinating challenges is you have employed physicians in large health systems, and you have independent physicians, oftentimes in small-town America, then you have this third sphere, which is academic medicine, and how do we then diagram these 3 spheres of healthcare. That’s the challenge that we all have. And how do we train medical students, residents, and fellows on population health? That’s one of my top goals.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More